In vitro culture of rodent spermatogonial stem cells (SSCs) has become an important asset in the study of mammalian SSC biology. Supported by added growth factors, SSCs divide in culture and form aggregates of stem/progenitor spermatogonia, termed clusters. Recent studies have shown that serial passaging of clusters results in long-term maintenance and amplification of the SSC pool and that this culture system can also be used for short-term semiquantification of SSC activity. Here, we report the development of an automated assay to assess the activity of rat stem/progenitor spermatogonia in vitro and its application for investigating the cytotoxicity of chemotherapeutic drugs on these cells. Cultures of EGFP-expressing rat spermatogenic cells allowed us to determine the number and two-dimensional surface area of clusters using an automated fluorescence imaging system, thereby providing quantitative data of SSC activity. Using this assay, we examined the germ cell toxicity of three drugs that are routinely used in testicular cancer therapy, namely, bleomycin, cisplatin, and etoposide, alone and in combination. All three drugs showed a significant and dosedependent reduction of cluster number and surface area, indicating their adverse effects specific to spermatogonia. The inhibitory concentration at which cluster number and surface area are inhibited by 50% (IC 50 ) was the lowest with etoposide and the highest with cisplatin, implying that etoposide was most toxic to spermatogonia in vitro. These results suggest that the SSC culture should provide an effective and efficient system to assess the germ cell toxicity of various drugs and chemical compounds.
INTRODUCTION
Spermatogonial stem cells (SSCs) are responsible for the lifelong production of spermatozoa throughout adulthood and for the transmission of genetic information to the next generation. Importantly, SSCs play a crucial role in the regeneration of spermatogenesis following cytotoxic insults such as cancer chemotherapies [1, 2] . However, evaluating the potential adverse effects of chemotherapeutic agents on spermatogonial stem/progenitor cells remains a challenging task, in part because of the absence of specific SSC markers and the complexity of spermatogenesis.
Most studies investigating the toxicity of anticancer agents on spermatogenesis and stem/progenitor spermatogonia have focused on whole-animal models [3, 4] . Although such in vivo approaches provide important toxicological information in a physiological context, they have several limitations. Cytotoxic effects on spermatogonia have been examined frequently using histology [3, [5] [6] [7] , a laborious step for toxicological studies of this cell population. While cytotoxic effects on SSCs can be evaluated using spermatogonial transplantation [8, 9] , this technique requires the appropriate preparation of recipient animals and the skillful microinjection of a germ cell suspension into the seminiferous tubules of individual recipient testes. In addition, measurement of SSC activity is done retrospectively, at least 2 mo after transplantation, by manually counting donor-derived colonies of spermatogenesis formed in recipient testes [10] [11] [12] . Hence, the transplantation assay is both labor intensive and time consuming and not amenable to assess the toxicity of multiple drugs at a range of doses.
In vitro culture systems have been recently developed that allow the long-term maintenance and expansion of rodent SSCs [13] [14] [15] [16] . In such systems, SSC-enriched germ cells are seeded on a feeder layer in a serum-free medium supplemented with glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2). Under these conditions, SSC-enriched germ cells divide and grow into tightly connected aggregates of cells termed clusters. These clusters consist of both SSCs and proliferating daughter spermatogonia that are phenotypically indistinguishable from each other [13, 14] . Importantly, clusters of stem/progenitor spermatogonia can be expanded and maintained in culture through serial passaging for several months. Furthermore, transplantation of cluster cells into recipient testes at any time during the culture period results in the formation of spermatogenic colonies, confirming the presence of functional SSCs among cluster cells [17, 18] . More recently, Yeh et al. showed that the number of clusters formed in vitro strongly correlated with the number of spermatogenic colonies produced following transplantation of these clusters into infertile recipient testes [19] , demonstrating that SSC activity can be detected in a semiquantitative manner and in a short period of time by counting cluster numbers. Thus, the mouse cluster culture was proposed as a SSC detection method that is an alternative to spermatogonial transplantation.
In this report, we examined whether cluster cultures could provide an alternative approach for evaluating the potential adverse effects of pharmacological agents, such as anticancer agents, on the spermatogonial stem/progenitor cell population in vitro. The goal of the current study was to develop a reproducible, short-term, and automated in vitro toxicity assay for rat stem/progenitor spermatogonia using cisplatin, etoposide, and bleomycin as model chemotherapeutic drugs. A transgenic rat strain in which the expression of enhanced green fluorescent protein (EGFP) is restricted to the germ cell lineage was used to establish cultures of rat EGFP þ clusters [20] . We developed a new method to enumerate clusters using an automated fluorescence imaging system and applied this in vitro assay to evaluate the adverse effect of the three anticancer drugs, alone or in combination, on clusters of stem/progenitor spermatogonia.
MATERIALS AND METHODS

Chemicals
All chemicals were obtained from Sigma Aldrich unless otherwise indicated. Cell culture reagents, including media, fetal bovine serum (FBS), trypsin, and human FGF2 were purchased from Invitrogen. Human recombinant GDNF and rat recombinant GFRa1-Fc fusion protein (GFRA1) were from R&D Systems. Cisplatin, etoposide, and bleomycin were purchased from LKT Laboratories.
Animal Care and Use
Homozygous SD-Tg(ROSA-EGFP)2-4Reh transgenic rats that exclusively express enhanced green fluorescent protein (EGFP) in the germ cell lineage (also termed GCS-germ cell specific) were kindly provided by R.E. Hammer (University of Texas Southwestern Medical Center, Dallas, TX) [20] . GCS-EGFP male pups on Postnatal Days 7-8 were used as donors of testis cells to induce cluster culture. Nude male mice (NCr-nu/nu) between 4 and 6 wk of age were purchased from Taconic Farms. The animals were maintained on a 12L:12D cycle with free access to rat chow and sterile water. All animal experiments were conducted in accordance with the regulations and policies of the Canadian Council on Animal Care and approved the McGill University Committee on Animals (protocol 4699).
Single-Cell Suspension Preparation
Homozygous GCS-EGFP rat pups were euthanized, and their testes were immediately dissected, freed of their tunica and placed into ice-cold phosphatebuffered saline (13 PBS, Ca 2þ /Mg 2þ free). Single-cell suspensions were prepared using a two-step enzymatic digestion as previously described [21] . Briefly, decapsulated testes were first incubated for 15 min at 378C into Dulbecco modified Eagle medium (DMEM; Invitrogen) containing 1 mg/ml collagenase (type IA, C9891; Sigma). The supernatant containing mostly testicular interstitial cells was decanted, and the sedimented seminiferous tubules were resuspended with 0.5 mg/ml trypsin (type 1, T8003; Sigma) and 1 lg/ml DNAse I (type 1, DN-25; Sigma) in DMEM and incubated for an additional 15 min at 378C prior to mechanical dissociation to a single-cell suspension using a flamed-tip glass Pasteur pipette. Remaining tissue debris was removed by filtration through a 40-lm nylon mesh cell strainer (BD Biosciences). Dissociated cells were centrifuged at 500 3 g for 5 min, resuspended in DMEM/10% FBS, and then immediately subjected to fluorescence-activated cell sorting (FACS). For each experiment, the testes of five to eight pups were used.
FACS
EGFP-expressing undifferentiated spermatogonia were isolated by FACS. Cell sorting was done using a FACSAria flow cytometer (Becton Dickinson Biosystems), and results were analyzed using Cell Quest software (Becton Dickinson Biosystems). During the acquisition process, forward and sidescatter plots were used to exclude cellular debris from the histogram analysis plots. On sorting, we obtained a clear bimodal distribution with an EGFP þ cell peak about five times smaller than the peak for EGFP À cells (Supplemental Fig.  S1 , all Supplemental Data are available online at www.biolreprod.org). Cells were sorted under sterile conditions at about 50 cells/sec, collected in 15-ml Falcon tubes containing DMEM/10% FBS, and maintained on ice until seeding.
Establishment of Rat Cluster Cell Lines
Sorted EGFP þ spermatogonia were cultured for cluster induction following protocols as previously described [14, 18] . The EGFP þ cells were counted using a hemacytometer and an inverted fluorescence microscope (Leica). EGFP þ spermatogonia were plated at a density of 0.5-1.25 3 10 5 cells/cm 2 on feeder cells in 24-well tissue plates with 1 ml/well of rat serum-free medium (RSFM). Feeder cells were prepared by treating STO (SIM mouse embryoderived Thioguanine-and Oubain-resistant SNL76/7) fibroblasts with mitomycin C, as described previously, and seeding at 5 3 10 4 cells/cm 2 [13, 14] . GDNF, GFRA1, and FGF2 (referred to hereafter as growth factors) were added to RSFM at concentrations of 40, 300, and 1 ng/ml, respectively. Under these conditions, EGFP þ spermatogonia developed into cell aggregates termed clusters by Day 6 after seeding. Visual inspection using a fluorescence microscope confirmed that all clusters were EGFP-positive. For long-term maintenance in culture, rat clusters were cultured as described previously with a medium change every other day and passaged onto a new feeder layer every 6-7 days [14, 18] . All cultures were maintained in a 378C atmosphere in a humidified chamber with 5% CO 2 in air.
Serial Dilution Assays
Serial dilution assays were done to measure the number of cluster-forming cells within the population of EGFP 
Drug Treatments
For toxicity assays, 5000 dissociated cells from cultured clusters were plated in black-walled, flat/clear-bottom, half-area 96-microwell plates (CLS3882; Corning Inc.) in a 0.1-ml volume of RSFM supplemented with growth factors. Chemotherapeutic drugs were added to cluster cultures on Day 4 postplating, and the effects of drugs were assessed 48 h later. The stock solution of each drug was prepared in 100% dimethylsulfoxide (DMSO; Fisher Scientific) and then diluted into RSFM to the desired concentrations prior to use. The concentration of the drug in the stock solution was 40 mM for cisplatin, 50 mM for etoposide, and 100 mM for bleomycin. The final DMSO concentration in the media of all drug assays was 0.1 % (v/v). Control cultures received 0.1% DMSO only.
Immunofluorescence Staining of Rat Clusters
Clusters were directly fixed in culture plates (96-well flat/clear-bottom black plates) following medium removal with 10% neutral-buffered formalin without washing and stored at 48C in the dark. For immunostaining, clusters were incubated with blocking buffer (3% [w/v] bovine serum albumin and 0.1% [v/v] Triton X-100 in PBS pH 7.4) for 20 min and then incubated with primary antibodies diluted in blocking buffer overnight at 48C. The following primary antibodies were used: mouse monoclonal anti-GFP antibody (catalog no. MAB 3580), rabbit polyclonal anti-phospho-histone H3 (Ser10) (catalog no. 06-570), and rabbit polyclonal anti-phospho-H2A.X (Ser139) (catalog no. 07-164), all from Millipore. ZBTB16 (also known as mouse monoclonal antipromyelocytic leukemia zinc finger or PLZF) (catalog no. OP128), was from Calbiochem, and mouse monoclonal anti-human RET (catalog no. MAB718) was from R&D Systems. On the next day, following three washes with PBS, clusters were incubated with secondary antibodies for 45 min at room temperature in the dark. Secondary antibodies used were Alexa Fluor 594-conjugated goat anti-mouse IgG, Alexa Fluor 594 goat anti-rabbit IgG (Molecular Probes), and sheep anti-mouse FITC-conjugated secondary antibody (GE Healthcare). Finally, the nuclei of cells in clusters were counterstained with 4,6 diamidino-2-phenylindole (DAPI; 0.1 lg/ml in PBS), and then VECTASHIELD Mounting Medium (Vector Laboratories) was added to each well. Images were acquired using an inverted epifluorescence microscope (Leica).
Automated Imaging System and Cluster Parameter Analysis
The images of clusters in 96-microwell plates were acquired automatically using the ImageXpress MICRO imaging system (Molecular Devices) equipped with a 103 Plan Fluor 0.30 NA objective (Nikon) and a CoolSNAP HQ digital CCD camera (Roper Scientific) at maximum resolution (696 3 520 pixels/ image, 1.29-micron/pixel resolution, with a 2 3 2 camera bin). For each well of a 96-microwell full-area plate (CLS3904, Corning Inc.), 48 pictures were captured, whereas in experiments using 96-microwell half-area plates (CLS3882, Corning Inc.), 30 pictures were captured. Subsequently, cluster numbers and surface area were analyzed using MetaXpress software (Molecular Devices). Clusters were defined as objects within the range of a minimum width of 35 lm and a maximum width of 85 lm, corresponding to groups or aggregates of at least six cells [19] . Cluster surface area was defined ANTICANCER DRUGS AND RAT SPERMATOGONIA 229 as the total area of all pixels inside the two-dimensional or projected perimeter of clusters that have fluorescence intensity above the set threshold value (intensity above local background 300 gray level). Counts were automatically exported to Excel. For dual-imaging channel experiments (two different fluorophores), channel 1 was used to measure the fluorescence of EGFP to identify discrete clusters and channel 2 to measure the fluorescence of Alexa Fluor 594-conjugated secondary antibody.
Transplantation of Cultured Rat Cluster Cells
Transplantation of rat EGFP cluster cells was done as previously described [14] . Briefly, nude mice were injected with busulfan (44 mg/kg) at 4-6 wk of age to eliminate endogenous spermatogenesis and then used as recipients at least 5 wk after the busulfan treatment. Cultured rat EGFP þ clusters were dissociated to single cells by trypsin digestion and resuspended in injection medium (DMEM, 10% FBS, 1 mg/ml DNase I, and 0.04% trypan blue). Approximately 7 ll of cluster cell suspension were injected into each recipient testis. Three months after transplantation, recipient testes were collected, and EGFP þ donor-derived colonies of spermatogenesis were visualized under a fluorescence stereomicroscope.
Statistical Analyses
For serial dilution assay, we calculated the root square (r 2 ) of the Pearson product moment correlation coefficient using Microsoft Excel. In drug testing experiments, each anticancer agent was tested in triplicate in at least three independent experiments using different cluster cultures. Dose-response curves were plotted, and IC 50 values (concentration of drug inducing a 50% decrease in cluster number or cluster surface area) were calculated using nonlinear regression analysis.
RESULTS
Establishment and Maintenance of EGFP-Expressing Rat Stem/Progenitor Spermatogonia Cultures
The development of an automated cluster-based assay system primarily requires cultures of cluster cells carrying a fluorescent marker transgene. Taking advantage of the restricted expression of EGFP in the germ cells of GCS-EGFP transgenic rats, we first isolated stem/progenitor spermatogonia (.99% purity) from Postnatal Day 7-8 testis cell suspensions using FACS (Supplemental Fig. S1 ) [20] . At this young age, undifferentiated spermatogonia are the only germ cells present in the seminiferous epithelium [21, 22] . To generate EGFP þ clusters, single dissociated EGFP þ spermatogonia were seeded on a feeder layer of STO cells in a serum-free medium supplemented with GDNF, GFRA1, and FGF2 [14] . In the presence of growth factors, EGFP þ spermatogonia divided and developed into clusters of tightly connected cells by Day 6 (Fig. 1, a-d) , whereas cells within the EGFP-negative fraction sorted by FACS did not form clusters (Supplemental Fig. S2 ). In the absence of growth factors, EGFP þ spermatogonia survived but did not form clusters during the 6 days of the culture period (Fig. 1, e and f) . Cultures of EGFP þ spermatogonia were subsequently maintained by passaging clusters onto new STO feeder layer every 6-7 days for up to five passage generations until used for assays.
To confirm the undifferentiated state of EGFP þ -cluster cells in culture, we analyzed the expression of undifferentiated spermatogonial markers, ZBTB16 and RET proteins [23] [24] [25] [26] . Using immunofluorescence, ZBTB16 staining was clearly localized in the nuclei of cluster cells, whereas the RET staining profile demonstrated a cytoplasmic membrane distribution. Thus, EGFP þ -cluster cells were comprised of undifferentiated spermatogonia (Supplemental Fig. S3) .
We assessed the presence of functional SSCs in EGFP þ cluster cultures using the spermatogonial transplantation assay. To this end, single-cell suspensions from cultures of rat EGFP þ clusters were transplanted into nude mouse testes. Three months later, we observed EGFP-positive colonies in recipient testes (Supplemental Fig. S4, a and b) . Further immunohistochemical analysis of EGFP þ colonies revealed that rat elongated spermatids/spermatozoa were formed within mouse tubules, indicating that complete spermatogenesis was regenerated from donor cluster cells (Supplemental Fig. S4, c-e) .
Together, these results demonstrate that functional SSCs were maintained in rat EGFP þ cluster cultures.
Determination of the Rat Spermatogonial Cluster-Forming Efficiency Using Automated Fluorescence Microscopy
In order to determine the sensitivity of the automated cluster-based assay, we assessed the relation between the number of EGFP þ cells placed in culture and that of clusters developing using a serial dilution assay. At Day 0, EGFP þ spermatogonia were plated in 96-well plates in serial dilutions that ranged from 0 to 20 000 cells per well. After 6 days of culture, images of clusters were acquired using the ImageXpress MICRO imaging system and analyzed for cluster numbers and area using MetaXpress, as described in Materials and Methods. As shown in Figure 2A , the number of clusters formed increased with an increase in the number of cells initially seeded at Day 0. Data obtained for cluster numbers and area were then analyzed using linear regression analysis. As Figure 2 , B and C, strong linear correlations between the cluster numbers and the number of cells initially plated per well and between cluster area and number of cells seeded per well were obtained with both r 2 correlation coefficients above 0.99. Thus, the slope of the regression line obtained from the cluster numbers reflects the proportion of cluster-forming cells present in the population of rat EGFP þ cells initially seeded. Under our culture conditions, we found that on average one cluster emerged from every 45 EGFP þ spermatogonia. The slope of the regression line calculated from cluster area may reflect the proliferation of seeded cells.
seen in
Notably, we did not observe a plateau phase even at the highest cell density examined (20 000 cells/well) for either parameter, indicating that the cluster growth did not reach a saturation level within this range of cell densities. The linearity in both cluster number and surface area was maintained even at a very low cell density (100 cells input/well), demonstrating the high sensitivity of the automated cluster assay (Fig. 2, B and  C) . In addition, the strong linearity observed between cell inputs and cluster numbers/areas suggest that the majority of cluster are of clonal origin (i.e., one cluster originates from a single cluster-forming cell) [19] . However, since suspensions of dissociated cells tend to group themselves if seeded at a high density, it is also possible that the formation of some clusters begins with such cell aggregations. Since there is a possibility that the maximum number of cells seeded (i.e., 20 000 cells/ well) could be reaching a plateau, we selected a density of 10 000 cells/well for further assays. Taken together, these results demonstrate that automated fluorescence microscopy (ImageXpress MICRO imaging system) can be used to rapidly count cluster numbers and analyze cluster surface area and to determine cluster-forming activity.
Comparison of Automated vs. Manual Cluster Quantification
Using the previously mentioned serial dilution experiments, we then compared the results of manual cluster counts to the results obtained using the automated imaging system. For manual counting, clusters were visually detected under a fluorescent microscope, and their number was recorded. We then used linear regression to evaluate cluster numbers as a function of cell dilutions. The cell surface area was difficult to assess manually, particularly when the culture contains a high number of clusters; therefore, we used only cluster numbers as assay readouts. Both quantification methods generated similar results with a strong linear correlation between cluster numbers and cell dilution per well (Supplemental Fig. S5 ). Hence, data obtained with the automated imaging system were in good agreement with those from the manual counts of clusters, further attesting to the reliability of the automated assay system and its ease of use. 
ANTICANCER DRUGS AND RAT SPERMATOGONIA cH2AX Immunofluorescence Staining and Automated Quantification of cH2AX-Positive Cluster Cells
In eukaryotic cells, histone H2AX (official symbol H2AFX), a variant of the nucleosome core histone H2A, is rapidly phosphorylated in response to DNA double-strand breaks induced by ionizing radiation and cytotoxic agents such as anticancer drugs [27] [28] [29] . Phosphorylated histone H2AX at serine 139, designated as cH2AX, forms distinct nuclear foci along megabase chromatin domains at or nearby the sites of DNA damage. Hence, a diffuse cH2AX staining is often indicative of cells experiencing DNA damages and potentially undergoing apoptosis [30] . Using an anti-cH2AX antibody, we determined the number of DNA-damaged cells within EGFP þ clusters (i.e., double positive for cH2AX and EGFP). After 6 days in culture, we observed that a small subset of cluster cells strongly expressed cH2AX and that these cells were almost exclusively located at the outer edge of the clusters (Fig. 3, a  and b) . In serial dilution experiments, we found that the number of cH2AX-positive cells per cluster tended to increase at higher cell concentrations, but there was no significant difference across the cell concentrations examined, suggesting that the proportion of DNA-damaged cells in a cluster is relatively constant (Fig. 4A) . On average, 0.5 cH2AX-positive cells were observed per cluster, regardless of the number of clusters that developed when at least 2000 cells were seeded per well. These results, obtained using the automated imaging system, indicate that a small number of cells retains DNAdamage after 6 days of culture, and these cells are located primarily at the periphery of a cluster.
Detection of Phospho-Histone H3Ser 10 and Evaluation of Cluster Cell Mitotic Activity
Phosphorylation of histone H3 at serine 10 is a wellcharacterized marker for mitosis that identifies cells in G2/M [31, 32] . Therefore, we determined the mitotic activity of cluster cells using an antibody that specifically recognizes histone H3 phosphorylated at serine 10 and counted the number of positive cells within EGFP þ clusters using the automated imaging system. Cells immunopositive for phosphorylated histone H3 (pH3) were observed in a subset of cluster cells, and, in clear contrast to cH2AX staining, the localization of pH3-positive cells was not restricted to cells at the periphery of clusters but also was found within the cluster structure (Fig. 3, c and d) . We then quantified the numbers of cells stained for pH3 per cluster in serial dilution experiments. We found that the number of pH3-positive cells per cluster remained constant regardless of the number of cells seeded per well (Fig. 4B) ; a statistical difference was found only between 100 and 20 000 cells. On average, one cell per cluster was found to be proliferating when at least 2000 cells were seeded per well. Thus, these results indicate that a small fraction of mitotically active cells are consistently present within clusters regardless of the total number of clusters per well. 
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Effects of Chemotherapeutic Drugs on Rat SSC Clusters
Having established an automated cluster assay system, we then applied it to test the effects of anticancer drugs on stem/ progenitor spermatogonia in vitro. To this end, we established dose-response curves for cisplatin, etoposide, and bleomycin, either alone or in combination. Rat EGFP þ clusters were cultured for 4 days under the standard SSC culture condition with RSFM supplemented with growth factors and then exposed to drugs for an additional 2 days (Fig. 5A) . Here, we used concentration ranges from 0.01 to 100 lM, depending on the drug. Cluster numbers and surface area were measured on Day 6 using the automated imaging system. The results obtained were compared to control cultures where only vehicle was added. Microscopic examination of the clusters revealed that rat EGFP þ clusters exhibited a striking change in morphology already 1 day after treatment with cisplatin. In contrast to control clusters that showed a tightly packed alignment, cisplatin-treated clusters were clearly smaller and surrounded by detaching cells (Fig. 5B, a and b) . Clusters exposed to etoposide and bleomycin showed a similar morphological change (data not shown). These observations suggest that each of these drugs elicits rapid cytotoxicity in cluster cells.
To assess the cytotoxic effects quantitatively, we determined both cluster numbers and surface areas using the automated system following exposure of clusters to the three drugs at different concentrations. As seen in Figure 6 , each of the three drugs tested reduced cluster numbers and surface area in a dose-dependent manner. The results showed varied kinetics of cytotoxic effects among cisplatin, etoposide, and bleomycin (Fig. 6, A-C) . Cisplatin did not significantly affect cluster numbers and surface area at 0.1 lM but reduced both parameters gradually with increasing doses. In contrast, etoposide and bleomycin showed more potent effects; both cluster numbers and surface area had declined drastically at 0.1 lM and remained at low levels across the higher doses examined. Based on these dose-response curves, we determined IC 50 values (lM) for each drug (Table 1 ). The highest IC 50 value measured was for cisplatin (1.88 lM), and the lowest IC 50 was obtained with etoposide (0.023 lM); the IC 50 value for bleomycin was intermediate at 0.197 lM. A similar trend of IC 50 values was seen when the values were calculated on the basis of cluster area. Hence, these results indicate that etoposide is the most toxic to cluster cells in vitro, while cisplatin appears the least toxic.
Since cisplatin induces DNA strand breaks that may trigger apoptosis and decrease cell proliferation if left unrepaired [30, 33] , we further characterized the adverse effects of cisplatin on cluster cultures by staining them for cH2AX and phosphorylated histone H3 at serine 10. As shown in Figure 7A , after 2 days of cisplatin treatment, the number of cH2AX-positive cells per cluster significantly increased at 0.1 lM cisplatin compared to control and decreased after treatment with 10 lM cisplatin (P , 0.05), suggesting that DNA-damaged cells were rapidly lost from clusters. Similarly, the numbers of pH3-positive cells per cluster were also significantly decreased with increasing concentration of cisplatin, indicating that some cluster cells remained mitotically active even at higher concentrations of cisplatin. We found a significant difference between the number of pH3-positive cells at 0.01 and 0.1, 5 and 10 lM cisplatin (P , 0.05) (Fig. 7B) . Thus, using specific antibody labeling and automated image analysis, this cluster assay allowed us to study quantitatively the effects of chemotherapeutic drugs on cluster cells in terms of DNA damage and mitotic activity.
Finally, we examined the combined effects of bleomycin, etoposide, and cisplatin (BEP). These drugs were mixed at equimolar concentrations to give a combined concentration from 0.001 to 0.1 lM; thus, for 0.1 lM BEP, each drug was added at a concentration of 0.033 lM. At 0.001 and 0.01 lM BEP, the cluster number did not show a significant difference from the control number; however, 0.1 lM BEP significantly reduced the cluster number to ;50% of control. The results of cluster area were in parallel to those of cluster numbers. It is noted that 0.1 lM BEP contained etoposide at 0.033 lM, which is similar to the IC 50 for this drug, implying that the significant effect observed at 0.1 lM BEP may be caused largely by etoposide. These results indicate that although each drug has cytotoxic effects on spermatogonia in vitro, there appears to be no synergistic effect; combined BEP toxicity does not become evident until the concentration of one of the three drugs reaches the IC 50 .
DISCUSSION
In this study, we first developed a new fluorescence-based assay to assess SSC activity using cultures of rat EGFP þ spermatogonia. Taking advantage of their EGFP expression, we used automated fluorescence microscopy and image analysis as a novel method to rapidly and reproducibly enumerate clusters formed by EGFP þ stem/progenitor spermatogonia in vitro. We then demonstrated that such a culture system, combined with automated fluorescence microscopy, can be used to assess the effects of anticancer drugs, cisplatin, etoposide, and bleomycin, alone or in combination, on the number and surface area of rat stem/progenitor spermatogonial clusters. 
ANTICANCER DRUGS AND RAT SPERMATOGONIA
Although the need for developing in vitro methods as alternative strategies to animal testing is gaining greater attention in the field of reproductive toxicity [34] , few methods are available. A variety of in vitro culture systems for testis germ cells have been described previously in the literature [35, 36] . However, few of these methods have been used to directly assess the adverse effects of anticancer drugs or other toxicants on stem/progenitor spermatogonia. A proposed alternative approach for in vitro toxicity testing using testis germ cells involves the use of immortalized testis cell lines [37, 38] .
Although these cell lines may have some characteristics of undifferentiated spermatogonia, their ability to restore complete spermatogenesis has not yet been demonstrated. Primary cultures of germ cells or cultures of seminiferous tubule segments provide other alternative approaches, but they have limited longevities in vitro and therefore require repetitive use of experimental animals to supply testicular tissue fragments or cells [36] . Instead, the culture system used in this study displays several distinct advantages. Rat EGFP þ stem/progenitor spermatogonia cultures can be expanded and maintained for long periods [14] and therefore can be used to continuously supply cells required for assays. Since these cells can be cryopreserved, target cells for the assay can be available at any time. Further, rat EGFP þ cluster cultures retain many in vivo properties of stem/progenitor spermatogonia. The regeneration of EGFP þ colonies of spermatogenesis within recipient testes after transplantation demonstrated the presence of functional SSCs among cultured germ cell clusters. The stem/progenitor phenotype of rat EGFP þ cluster cells was further confirmed by analyzing the expression of known undifferentiated spermatogonial cell markers, GNDF receptor RET and transcription repressor ZBTB16 [9, 18, 19] . Taken together, we propose that our culture system provides a suitable model of early FIG. 6 . Effects of chemotherapeutic agents, cisplatin, etoposide, and bleomycin on in vitro cultured rat EGFP þ clusters. For cytotoxicity assays, clusters were first grown for 4 days without drug. At Day 4, culture medium was changed and replaced by a fresh one with drug or vehicle. Following culture for 2 days, rat EGFP þ clusters were fixed and then counted using an automated fluorescence microscope, as described in Materials and Methods. The cytotoxicity of each drug for rat EGFP þ clusters was assessed by plotting concentration-response curves for the cluster numbers (left axis) and surface area (right axis). Clusters in 96-well plates were treated with cisplatin (A), etoposide (B), bleomycin (C), or a combination of the three drugs (D). Cluster number and surface area were determined 48 h later. Data shown represent the average of three independent experiments, each containing three replicates. The data are presented as the means 6 SEM. 234 spermatogenesis in which the effects of toxic compounds on stem/progenitor spermatogonia can be assessed directly. Despite their utility, cluster cultures also have some limitations. Quantitative cluster-forming assays for rodent SSCs require clusters to be manually counted using a brightfield microscope. The use of direct observation to enumerate clusters is a time-consuming and labor-intensive procedure in which consistent objectivity is difficult to achieve. This greatly limits the number of assay conditions, such as the number of different drugs and their concentrations that can be tested.
In this study, we took advantage of the restricted EGFP expression in the germ cell lineage of GCS-EGFP transgenic rats and established EGFP þ cluster cultures using previously reported culture conditions [14] . To date, SSC culture systems have been developed for several rodent species, including mouse, hamster, and rat [13] [14] [15] [16] 39] . However, rat is a wellestablished model in reproductive toxicology; the toxicity of several anticancer drugs to testis germ cells was characterized previously using in vivo rat models, although data on the specific response of spermatogonia to anticancer drugs are often limited [4, 42] . To the best of our knowledge, no previous study has reported the use of a rat SSC culture system in toxicity studies. The ease and rapidity of accurately counting rat EGFP þ clusters in culture using the automated imaging system prompted us to use this culture system to assess anticancer drug toxicity in vitro.
Cisplatin, etoposide, and bleomycin are used clinically in a combination chemotherapy regimen (BEP regimen) for the treatment of patients with metastatic germ cell tumors. It is well documented that one of the major side effects of this BEP regimen is damage to the spermatogenic system, resulting in a transient or permanent decrease in sperm production in patients shortly after treatment [3, 40, 41] . Previous studies in animal models have also well documented the effects of these three anticancer agents individually on spermatogenesis [7, 42, 43] . In addition, we previously showed in the rat that a combined regimen of cisplatin, etoposide, and bleomycin induced disruption of spermatogenesis that resulted in a drastically decreased sperm production rate and altered progeny outcome [44, 45] .
Here, using the rat EGFP þ cluster culture system, we showed that all three drugs have concentration-dependent toxic effects on cluster numbers and surface area. Thus, the concentration at which toxicity was observed varied significantly among the drugs used. To gain more insight into the mechanisms of cisplatin toxicity, cH2AX labeling has been employed to demonstrate that a subpopulation of cluster cells exhibit diffuse-nuclear staining indicative of DNA-damaged cells, whereas pH3 staining provided a measure of the numbers of mitotically active cells within clusters. After drug treatment, cH2AX-positive cells that are experiencing DNA damage likely undergo cell death. It is interesting to note that both cH2AX-positive cells and detaching cells are found in periphery of a cluster ( Fig. 5 and Supplemental Fig. S6 ). These observations suggest that drug treatments likely induce apoptosis of cluster cells (i.e., spermatogonia and SSCs), leading to a decline in cluster number and surface area. This possibility is supported by previous in vivo studies in which cisplatin was shown to induce germ cell apoptosis with targeted cells including spermatogonia [5, 46] . Similar results were also obtained when etoposide alone or a combination of bleomycin, etoposide, and cisplatin was given to rats [7, 45] . Alternatively, the drug treatments may affect the expression of cell adhesion molecules that could also lead to detachment of cluster cells, in addition to apoptosis induction, resulting in the reduction of cluster number and surface area. Further studies are necessary to clarify these possibilities. Nonetheless, our study indicates that the rat EGFP þ SSC assay may be useful for cytotoxic testing as well as for investigating mechanisms of toxicity.
Our data clearly indicate that etoposide is more toxic to clusters of stem/progenitor spermatogonia cultured in vitro than bleomycin and cisplatin. Although several investigations have reported that in vivo cisplatin or etoposide exposures are often associated with impaired spermatogenesis, no comparative data are available on their specific effects on stem/progenitor spermatogonia either in vitro or in vivo. In addition, most of these in vivo studies have used different routes of administration and durations of treatment. Since our study is the first report about drug effects imposed specifically on spermatogonia in vitro, a direct comparison of past studies with our current results is difficult. In order to assess our in vitro results with in vivo data, experiments involving transplantation of cluster cells after treatment will be required to determine the toxicity of these anticancer drugs specifically on SSCs. The results obtained in this study will allow us to primarily identify the doses of individual drugs to be examined alone and in combination by the transplantation assay.
In conclusion, our results indicate that the automated fluorescence-based SSC assay developed in this study may provide new insights into the adverse effects of anticancer drugs on stem/progenitor spermatogonial activity in vitro. It may also offer unique opportunities for screening assays using libraries of small molecules to search for molecules that may improve proliferation or survival of stem/progenitor spermatogonia in vitro. We anticipate that such a fluorescent-based cluster assay will serve as a useful tool for assessing the potential cytotoxicity of new drugs and environmental toxicants. In light of a recent report on in vitro culture conditions for the propagation of human SSCs [47] , human SSC culture should also be applicable to cytotoxic studies, as shown in this study, and could also be extended to a patientspecific toxicological analysis on undifferentiated spermatogonia in the future.
